HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Abandons Negotiations With Cosmetics Industry On Legislative Plan

This article was originally published in The Rose Sheet

Executive Summary

Negotiations between FDA and the cosmetics industry on a legislative plan to modernize regulatory oversight of cosmetics have come to a halt, with FDA Deputy Commissioner for Foods and Veterinary Medicine Michael Taylor asserting in a March 6 letter that there is no longer common ground between the groups. The Personal Care Products Council urges the agency to return to the table and work out an agreement.

Advertisement

Related Content

PCPC, FDA Negotiate Oversight Bill With Possible State-Law Preemption
Advertisement
UsernamePublicRestriction

Register

RS018937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel